NANOVIRICIDES, INC. Employee Benefits and Share-based Compensation
NANOVIRICIDES, INC. (NNVC) reported Employee Benefits and Share-based Compensation of $77.49 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-21.
Discontinued › Notes › Compensation Related Costs › General › Income Statement Compensation Expense Items
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2018-05-21
- NANOVIRICIDES, INC. employee benefits and share-based compensation for the quarter ending 2018-03-31 was $77.49K, a 87.03% decline year-over-year.
- NANOVIRICIDES, INC. employee benefits and share-based compensation for the quarter ending 2017-12-31 was $19.84K, a 16.67% decline year-over-year.
- NANOVIRICIDES, INC. employee benefits and share-based compensation for the quarter ending 2017-09-30 was $25.23K, a 26.37% decline year-over-year.
- NANOVIRICIDES, INC. employee benefits and share-based compensation for the quarter ending 2017-03-31 was $597.69K.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month |
|---|---|---|---|
| 2018-03-31 | $77.49K 10-Q · filed 2018-05-21 | $97.33K derived: sum of 2 quarters · filed 2018-05-21 | $122.56K 10-Q · filed 2018-05-21 |
| 2017-12-31 | $19.84K 10-Q · filed 2018-02-20 | $45.06K 10-Q · filed 2018-02-20 | |
| 2017-09-30 | $25.23K 10-Q · filed 2017-11-14 | ||
| 2017-03-31 | $597.69K 10-Q · filed 2017-05-15 | $621.50K derived: sum of 2 quarters · filed 2017-05-15 | $655.76K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $23.80K 10-Q · filed 2017-02-14 | $58.07K 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $34.26K 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |